Estimates were made in vivo in rabbits of the relative beta-receptor blocking potency and duration of action of propranolol and practolol. In further experiments groups of litter mates were injected twice daily with approximately equi-active amounts of propranolol or practolol, or with saline, for several weeks. The heart weights of the treated animals were significantly lower than those of the controls, the water contents were higher, and the dry weight differences were highly significant; -16.8% after 2 mg/kg bd propranolol for six weeks and -33.8% after 10 mg/kg practolol. (The treated animals grew less rapidly than the controls; when corrected for body weight these figures were -11.9% and -20.4%, respectively.) In the practolol group, but not the propranolol group, the duration of the atrial intracellular potentials was prolonged. There was no evidence that the prolonged treatment with either drug had a negative inotropic effect, or reduced positive inotropic responses to isoprenaline.
This paper proposes a combined algorithm for the detection of ventricular fibrillation and its accwately discriminatr 'on from other rhythms. A total of 95 sinus rhythms, 15 monomorphic ventricular tachycardias, 33 atrial fibrillations, 39 supraventricular tachycardias and 30 ventricular fibrillations were analyzed. The algorithm tests three characteristics of the ventricular fibrillation through the estimation of the isoelectric potential, the power spectrum and the coherence spechum. The algorithm allowed a reliable distinction of ventricular fibrillation fiom the other rhythms. The aim of this algoritbm is to be used in any external device procesSing the d a c e ECG signals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.